期刊文献+

奥沙利铂的安全性评价 被引量:79

Safety assessment of oxaliplatin
下载PDF
导出
摘要 奥沙利铂作为第三代铂类抗癌药物 ,具有特异的细胞毒性。其与 5 氟尿嘧啶和亚叶酸联合应用作为一线治疗转移性结肠癌。其抗癌作用明确 ,具有较顺铂和卡铂疗效好、毒性低等特点 ,在抗肿瘤治疗上应用比较广泛。奥沙利铂主要不良反应为感觉神经毒性和胃肠道反应等。本文就奥沙利铂临床使用的安全性问题与顺铂、卡铂、伊立替康进行对比评价。 Oxaliplantin,a platinum antineoplastic agent of the third generation,now is used as the first line therapy for treatment of metastatic colorectal cancer in combination with 5-fluorouracil and folinic acid.Neurotoxicity and GI reactions are the main adverse reactions of oxaliplatin.In this paper,the safety of oxaliplatin in clinical use is evaluated in comparison with cisplatin and carboplatin.
出处 《中国新药杂志》 CAS CSCD 北大核心 2003年第7期567-569,共3页 Chinese Journal of New Drugs
关键词 奥沙利铂 药物不良反应 神经毒性 oxaliplatin adverse reaction neurotoxicity
  • 相关文献

参考文献16

  • 1孙燕,管忠震,金懋林,李维廉,李丽庆,石廷章,周立中,隋广杰,许立功,宋恕平,许德凤,李容,李扬,黄富麟,张嘉庆,张和平,鞠利雅.奥沙利铂单药或与氟尿嘧啶-甲酰四氢叶酸联合应用治疗晚期大肠癌Ⅱ期临床试用报告[J].癌症,1999,18(3):237-240. 被引量:344
  • 2胡发明.奥沙利铂的不良反应和安全性[J].国外医药合成药·生化药·制剂分册,1999,20(3):184-185.
  • 3Misset JL. Oxaliplatin in practice [ J ] . Br J Cancer, 1998, 77(Suppl 4):S4- S7.
  • 4Graham MA, Lockwood GF, Greenslade D, et al. Clinical pharmacokinetics of oxaliplatin; a critical review[ J ] . Clin Cancer Res ,2000,6(4) : 1205 - 1218.
  • 5Levi F, Metzger G, Massari C, et al. Oxaliplatin: pharmacokinetics and chronopharmacological aspeets[J]. Clin Pharmacokinet,2000,38(1) : 1 - 21.
  • 6Luo FR, Wyrick SD, Charley SG. Biotransformations of oxaliplatin in rat blood in vitro[J] .J Biochem Mol Toxicol ,1999 ,13(3-4):159- 169.
  • 7Gamelin E, LeBouil A, Boisdron-celle M, et al. Cumulative pharmacokinetic study of oxaliplatin, administered every three weeks, combined with 5-fluomuracil in colorectal cancer patients[J]. Clin Cancer Res, 1997,3(6) :891 - 899.
  • 8Raymond E, Chaney SG, Taamma A, et al. Oxaliplatin: a review of preclinical and clinical studies [ J ]. Ann Oncol, 1998,9 ( 10 ) :1053- 1071.
  • 9Fukuda M, Ohe Y, Kanzawa F, et al. Evaluation of novel platinum complexes,inihibitors of topoisomerase Ⅰ and Ⅱ in nonsmall cell lung cancer (NSCLC) subllnes resistant to cisplatin[ J ]. Anticancer Res, 1995,15 (2) : 393 - 398.
  • 10Mathe G,Kidani Y, Noji M, et al .Antitumor activity of 1-OHP in mice[J]. Cancer Lett, 1985,27 (2):135-143.

二级参考文献2

共引文献346

同被引文献463

引证文献79

二级引证文献415

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部